Bellicum Pharmaceuticals Inc. buy stratec
Start price
04.01.18
/
50%
€84.25
Target price
03.12.18
€180.40
Performance (%)
-47.97%
End price
03.12.18
€43.84
Summary
This prediction ended on 03.12.18 with a price of €43.84. The BUY prediction by stratec for Bellicum Pharmaceuticals Inc. performed very badly with a performance of -47.97%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellicum Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by stratec for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 04.01.2018 der Buy-Einschätzung von tamam mit dem Kursziel 20$ zu.Überschrift: BLCM´s Ziel: eine broad-label-approval zur Behandlung von bösartigen und nicht-malignen Blutkrankheiten
(Vom Mitglied beendet)
Stopped prediction by stratec for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.75
08.03.20
08.03.20
€12.00
21.03.20
21.03.20
-49.63%
21.03.20
21.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.80
23.02.20
23.02.20
€12.00
08.03.20
08.03.20
-1.54%
08.03.20
08.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
08.02.20
08.02.20
€12.00
22.02.20
22.02.20
-23.53%
22.02.20
22.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
06.01.20
06.01.20
€20.00
08.02.20
08.02.20
-16.39%
08.02.20
08.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.65
12.11.19
12.11.19
€10.00
31.12.19
31.12.19
55.56%
31.12.19
31.12.19
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.84
02.12.18
02.12.18
€72.16
12.11.19
12.11.19
-82.55%
12.11.19
12.11.19